| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 05/03/2006 | CN1768059A Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 05/03/2006 | CN1768041A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 05/03/2006 | CN1254476C Dihydroimidazo[5,1-a]-beta-carboline derivatives, method for preparing same and use thereof as medicine |
| 05/02/2006 | US7038050 Method for the preparation of highly pure 1-androstene derivatives |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 04/27/2006 | WO2006042481A1 Method of obtaining clopidogrel |
| 04/27/2006 | US20060089375 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | DE19741739B4 Supramolekulares Paarungssystem, dessen Herstellung und Verwendung Supramolecular mating system, its preparation and use |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1648872A2 Aryl fused azapolycyclic compounds |
| 04/26/2006 | EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | CN1763039A Indolizine carboxyl acid analog compound synthesis method |
| 04/26/2006 | CN1253455C 2-3-methylen-dioxy dibenzo [a,g] quinolizine onium hydrochloride and its uses in treatment of diabete |
| 04/26/2006 | CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/20/2006 | WO2006040329A1 1 ibeta- hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/20/2006 | WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 04/20/2006 | WO2006023669A3 Process for the production of levorphanol and related compounds |
| 04/20/2006 | US20060084671 Process for the preparation of pure finasteride |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/19/2006 | EP1646659A2 Improved pharmaceutical drug candidates and methods for preparation thereof |
| 04/19/2006 | EP1646640A1 Method for the preparation of highly pure 1-androstene derivatives |
| 04/19/2006 | EP1646388A2 Cytotoxic indeno and isoindoloisoquinolones |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1051177B1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 04/19/2006 | CN1761673A Guanidine derivatives and use thereof as neuropeptide FF receptor antagonists |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1760195A Method for separating and purifying 9-nitro camptothecin |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252052C Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 04/18/2006 | US7030244 Colorant compounds containing copolymerizable vinyl groups |
| 04/18/2006 | US7030122 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| 04/18/2006 | US7029835 Photothermographic element comprising improved base precursors and methods for their use |
| 04/18/2006 | CA2207443C Tricyclic compounds |
| 04/18/2006 | CA2205230C N-hydroxypiperidines as superoxide radicals scavengers |
| 04/13/2006 | WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | CA2582294A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 04/12/2006 | EP1644336A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
| 04/12/2006 | EP1644012A1 Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in manufacture of medicaments |
| 04/12/2006 | EP1549647B1 Substituted c-imidazo¬1,2-a|pyridin-3-yl-methylamines |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | CN1250547C Process for extracting matrine and sophoridine from sophora alopecuroide |
| 04/12/2006 | CN1250546C Tetrahydropyrido compound |
| 04/12/2006 | CN1250529C Rosinyl acridine its producing method and use thereof |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/12/2006 | CN1250221C Treatment of female sexual dysfunction |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel |
| 04/11/2006 | CA2162382C Intercalators having affinity for dna and methods of use |
| 04/11/2006 | CA2157128C Camptothecin derivatives, preparations thereof and antitumor agents |
| 04/06/2006 | WO2006035967A1 Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor |
| 04/06/2006 | WO2006035303A1 Muscarinic receptor antagonists |
| 04/06/2006 | WO2006035195A1 Preparation of opiate analgesics by reductive alkylation |
| 04/06/2006 | US20060074241 Enantioselective process |
| 04/05/2006 | EP1641777A1 Indole derivatives with apoptosis-inducing effect |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641464A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249064C Tosylate and benzene sulfonate of pyrazolopy ridone compound |
| 04/05/2006 | CN1249062C Substituted imidazopyridines |
| 04/04/2006 | USRE39056 4-Azasteroids for treatment of hyperandrogenic conditions |
| 04/04/2006 | US7022855 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 04/04/2006 | US7022854 Crystal structure; dissolving in alcoholic solvent; solvent removal adding ester; filtration |
| 04/04/2006 | US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/29/2006 | CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 03/29/2006 | CN1247587C Tert. alkylphenoxy substituted polycyclic compounds |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/28/2006 | US7019141 Quinolones with anti-HIV activity |
| 03/28/2006 | US7019139 Quinolinones and uses thereof |
| 03/28/2006 | US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides. |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063793 Method of inhibiting neurotrophin-receptor binding |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | CA2579847A1 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 03/22/2006 | EP1549650B1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/22/2006 | EP1200433B1 C-6 RING-SUBSTITUTED PYRIDO[1,2-a]BENZIMIDAZOLE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS |
| 03/22/2006 | CN1751027A Spermicidal and/or antifungal composition and methods of using the same |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015327 Anthrapyridone compound containing two phenyl rings substituted by sodium sulfonate groups; excellent in light fastness and water fastness |
| 03/21/2006 | US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example |
| 03/21/2006 | US7014925 4,4'-bis-(spiro 9-fluorene-9'-acridin-10-yl)biphenyl for example, having visible light emissive, hole-transport, electron transport or bipolar-transport properties; use as emissive layer, charge transport layer, or as host material for such layers |
| 03/16/2006 | WO2006029167A2 Treatment of diseases using nalmefene and its analgos |
| 03/16/2006 | WO2006028875A1 Phenanthridine carbonyl phenols as cytokine modulators |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | WO2005090310A3 Process for preparing cyclohexanediacetic acid monoamide |
| 03/16/2006 | US20060058337 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression |
| 03/16/2006 | US20060058334 provides substantially pure desloratadine having an HPLC purity greater than 99.5% and having an absorbance less than 0.15 Au at 420 nm for a 5% w/v solution in methanol; acidic hydrolysis; 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine; allergic rhinitis |